New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
08:06 EDTDPRXDipexium Pharma' begins patient enrollment for clinical trial with Locilex
Dipexium Pharmaceuticals announced it has initiated patient enrollment in the second of two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, evaluating Locilex, the company's novel, broad-spectrum, topical antibiotic peptide, for the treatment of patients with mild infections of diabetic foot ulcers, or Mild DFI. According to medical literature, approximately 47% of all patients with diabetic foot infections first present at the mild stage.
News For DPRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2015
08:08 EDTDPRXDipexium Pharmaceuticals reaches 50% enrollment in Locilex Phase 3 trial
Dipexium Pharmaceuticals' OneStep-1 Phase 3 clinical trial has passed the 50% enrollment milestone. OneStep-1 and OneStep-2 are identical, pivotal Phase 3 clinical trials being conducted under a Special Protocol Assessment agreement between the FDA and Dipexium for evaluation of Locilex for the treatment of patients with mild infections of diabetic foot ulcers. The company anticipates completing enrollment and filing a New Drug Application for FDA approval in 2016.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use